“…For patients with cirrhotic ascites accompanied by SBP, 1.5 g/kg HSA is administered on Day 1 and then 1 g/kg on days 2-5. There was a marked decline in the incidence of renal failure, mortality during hospitalization, and 3-month mortality in patients with cirrhosis who received HSA compared with those who did not (4.7, 3.1, and 7% compared with 25.6, 38.2, and 47%, respectively) [44]. In recently ANSWER study, long-term HA (40 g twice weekly for 2 weeks, and then 40 g weekly for up to 18 months) administration prolongs overall survival and might act as a disease modifying treatment in patients with decompensated cirrhosis [45].…”